FANCI, ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.175
EU - Europa 6.093
AS - Asia 3.255
SA - Sud America 493
AF - Africa 124
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 50
Totale 19.279
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.048
RU - Federazione Russa 1.724
PL - Polonia 1.180
IT - Italia 1.152
SG - Singapore 923
CN - Cina 667
SE - Svezia 544
HK - Hong Kong 519
IE - Irlanda 456
VN - Vietnam 439
BR - Brasile 381
KR - Corea 289
UA - Ucraina 268
DE - Germania 192
FI - Finlandia 184
FR - Francia 158
GB - Regno Unito 116
IN - India 99
AU - Australia 88
CA - Canada 86
TR - Turchia 53
BD - Bangladesh 49
NL - Olanda 49
JP - Giappone 45
JO - Giordania 43
AR - Argentina 37
ID - Indonesia 32
NG - Nigeria 30
CI - Costa d'Avorio 28
CH - Svizzera 23
IQ - Iraq 22
MX - Messico 20
CO - Colombia 19
ZA - Sudafrica 16
ES - Italia 14
EC - Ecuador 13
VE - Venezuela 13
CL - Cile 11
PK - Pakistan 11
SC - Seychelles 10
SA - Arabia Saudita 8
EG - Egitto 7
MA - Marocco 7
PY - Paraguay 7
KE - Kenya 6
NP - Nepal 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
PH - Filippine 5
RS - Serbia 5
AT - Austria 4
KZ - Kazakistan 4
LT - Lituania 4
PE - Perù 4
PS - Palestinian Territory 4
SN - Senegal 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
OM - Oman 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BI - Burundi 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GA - Gabon 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
PT - Portogallo 2
SV - El Salvador 2
TG - Togo 2
TN - Tunisia 2
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EU - Europa 1
GH - Ghana 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
Totale 19.224
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.926
Warsaw 1.178
Ashburn 804
Fairfield 800
Singapore 662
Chandler 535
Dublin 454
Jacksonville 412
Hong Kong 398
Woodbridge 379
Seattle 303
Cambridge 296
Houston 289
Seoul 289
Wilmington 254
Milan 236
San Jose 173
The Dalles 161
Buffalo 158
Princeton 157
Beijing 144
Ho Chi Minh City 124
Los Angeles 122
Lauterbourg 114
Rome 107
Boston 101
Hanoi 101
Hefei 94
Boardman 93
Ann Arbor 87
Melbourne 87
Altamura 69
Lawrence 68
Dallas 64
Mumbai 61
San Diego 59
Medford 58
Moscow 58
Council Bluffs 54
Helsinki 54
Florence 50
Kent 39
New York 39
Naples 38
Tokyo 37
Izmir 35
Shanghai 34
Turin 34
Norwalk 30
Clifton 29
Redondo Beach 29
São Paulo 29
Abidjan 28
Abuja 28
Dong Ket 25
Falls Church 24
Toronto 23
Uitgeest 23
Bologna 21
Haiphong 20
Montreal 20
Bari 19
Da Nang 18
Figino 18
Jakarta 18
Frankfurt am Main 17
Phoenix 16
Verona 16
Atlanta 15
Brescia 14
Munich 14
Orem 14
Bern 13
Catania 13
Hillsboro 12
Palermo 12
Rio de Janeiro 12
Genoa 11
Guangzhou 11
Tianjin 11
Venice 11
Biên Hòa 10
Brooklyn 10
London 10
Andover 9
Chicago 9
Amman 8
Amsterdam 8
Belo Horizonte 8
Denver 8
Guayaquil 8
Hải Dương 8
Santo André 8
Taranto 8
Baghdad 7
Dhaka 7
Laurel 7
Reggio Emilia 7
San Francisco 7
Barcelona 6
Totale 12.656
Salva come PNG Salva come JPEG
Nome #
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 354
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals 340
Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. 305
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). 304
Two Years of a fungal aerobiocontamination survey in a Fiorentine haematology ward. 285
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study 275
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study). 272
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality. 256
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL). 250
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry. 246
Unusual Methylobacterium fujisawaense infection in a patient with acute leukaemia undergoing hematopoietic stem cell transplantation: first case report 236
AFLP epidemiological investigation of an outbreak of Pseudomonas aeruginosa sepsis in stem cell transplantation patients 223
Molecular characterization of Acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis 216
Isolation of Trichosporon in a hematology ward. 202
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey 199
Fisiopatologia e morfologia del sangue e degli organi emopoietici 198
Tissue persistence of parvovirus B19 genotypes in asymptomatic persons 196
ACUTE HEPATITIS C VIRUS INFECTION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES 193
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey. 190
A prospective, open-label noncomparative study with piperacillin-tazobactam monotherapy as management of Fever in patients with acute leukemia. 189
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study. 189
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. 184
Human parvovirus B19 (B19V) infection in systemic sclerosis patients. 182
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 181
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 180
PRESENCE OF TT VIRUS (TTV) DNA IN BONE MARROW CELLS FROM HAEMATOLOGIC PATIENTS 179
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration? 177
Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study. 176
ARSENIC TRIOXIDE THERAPY FOR RELAPSED ACUTE PROMIELOCYTIC LEUKEMIA: AN USEFUL BRIDGE TO TRANSPLANTION 174
Human parvovirus B19 infection in bone marrow transplantation patients 171
ETUDE DE L'AEROBIOCONTAMINATION FONGIQUE EN MILIEU HOSPITALIER A FLORENCE 166
Molecular analysis of population structure and antibiotic resistance of Klebsiella isolates from a three-year surveillance program in Florence hospitals, Italy 165
Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin 164
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin. 164
Advanced mast cell disease: an Italian Hematological Multicenter experience. 164
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 162
Human herpesvirus 8 (HHV-8) DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy blood donors. 157
Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature 154
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. 152
Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration? 152
BORTEZOMIB PLUS CONVENTIONAL CHEMOTHERAPY IN POOR RISK ACUTE MYELOID LEUKAEMIA: A PILOT STUDY 151
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia. 151
THERAPY OF INFECTIONS IN HAEMATOLOGICAL MALIGNANCIES 150
EMPIRIC ANTIFUNGAL STRATEGIES FOR ACUTE LEUKEMIA PATIENTS 149
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study 149
Attualità diagnostiche e nuove possibilità terapeutiche nelle infezioni fungine in oncoematologia 149
FLUDARABINE, CYTARABINE AND TOPOTECAN (FLAT) AS INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA IN THE ELDERLY: A PRELIMINARY REPORT 148
EPIDEMIOLOGIA MOLECOLARE CON AFLP DI P. AERUGINOSA ISOLATI DA PAZIENTI TRAPINTATI DI MIDOLLO OSSEO 146
Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. 146
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. 146
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. 144
Molecular epidemiological investigation of an outbreak of Pseudomonas aeruginosa infection in an SCT unit. 144
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 144
ANTIFUNGAL STRATEGIES IN ACUTE LEUKEMIC PATIENTS WITH PERSISTENT FEBRILE NEUTROPENIA 143
A prospective survey of febrile events in hematological malignancies. 143
SUBCUTANEOUS CAMPATH-1H IN REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: FEASIBILITY AND EFFICACY 141
MOLECULAR EPIDEMIOLOGY BY AFLP ANALYSIS OF PSEUDOMONAS AERUGINOSA STRAINS FROM BONE MARROW TRANSPLANTATION PATIENTS AND HOSPITAL ENVIRONMENT 141
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry. 141
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia 140
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study 139
GEOTRICHUM CAPITATUM FUNGEMIA IN A PATIENT WITH ACUTE MYELOID LEUKEMIA: A CASE REPORT 138
TREATMENT OF STOMATOCOCCUS MUCILLAGINOSUS BLOODSTREAM INFECTION IN TWO ACUTE LEUKEMIA PATIENTS, FIRST REPORTED AT OUR CANCER CENTER 137
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial 136
Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards. 134
The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects. 133
Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study. 132
Pulmonary mucormycosis with cervical lymph node involvement in a patient with acute myeloid leukaemia: a case report. 131
Central venous catheter-related infection due to Candida membranaefaciens, a new opportunistic azole-resistant yeast in a cancer patient: a case report and a review of literature. 131
Pseudomonas aeruginosa sepsis in stem cell transplantation patients. 130
Management of fever in neutropenic patients with acute leukemia : current role of ceftazidime plus amikacin as empiric therapy 129
Molecular epidemiological investigation of an outbreak of pseudomonas aeruginosa sepsis in stem cell transplantation patients 129
Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation 129
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients 128
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: A case report and literature review. 127
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections 126
The control of infections from candida albicans in patients with haemolymphoblastosis 126
Mucormicosi polmonare con coinvolgimento linfonodale laterocervicale in un paziente con leucemia acuta mieloide 126
Microbiologic survey with biotyping methods in haematological patients. 125
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey. 125
Surveillance mycologique chez les patients soumis à greffe de moelle osseuse à Florence. 124
ISOLATION FREQUECY AND ANTIMICROBIAL SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN NEUTROPENIC PATIENTS WITH ACUTE LEUKEMIA 120
Anemia macrocitica in gravidanza complicata da giardiasi: descrizione di un caso 120
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients. 120
Effect of anesthesia and surgery on phagocytic and candidicidal activity of polymorphonuclear cells 119
Systemic mastocytosis. A Gimema multicentric survey 119
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy 119
Arsenic trioxide therapy for relapsed acute promyelocitic leukemia: a bridge to transplantation. 118
Ofloxacin versus Cotrimoxazole for Prevention of Infections inGranulocytopenic Patients 118
Nosocomial infections due to enterococci in patients with acute leukemia 117
Caspofungin for the treatment of candidaemia in patients with haematological malignancies. 117
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies : a randomized, placebo-controlled, double-blind, multicenter trial 117
Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients. 116
Fungal infections in hematological neoplastic disease: the possibility of chemoprophylaxis. 115
High dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-Myl) in relapsed or refractory AML patients 115
High response rates and reduced first dose reactions with subcutaneous alemtuzumab in patients with relapsed and refractory CLL 115
Sorveglianza delle infezioni fungine nelle leucemie acute. 114
Fatal acute hepatitis C virus infection in patients with hematological malignancies. 114
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). 112
High Dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-MYL) in Relapsed or Refractory AML Patients. 111
Zygomycosis in haematological patients. Results of a prospective analysis 110
Totale 16.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022818 0 94 36 44 34 28 34 60 62 27 136 263
2022/20232.054 244 247 92 175 199 426 254 123 194 10 66 24
2023/2024530 27 91 141 35 22 38 25 83 3 14 32 19
2024/20254.962 169 491 311 725 1.574 757 72 283 222 115 159 84
2025/20265.354 484 743 423 339 543 256 674 344 332 279 106 831
2026/2027382 194 188 0 0 0 0 0 0 0 0 0 0
Totale 19.279